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Human T-lymphotropic virus type 1 (HTLV-1) and other members of the Deltaretrovirus
genus code for a regulatory protein named Rex that binds to the Rex-responsive
element present on viral mRNAs. Rex rescues viral mRNAs from complete splicing
or degradation and guides them to the cytoplasm for translation. The activity of Rex
is essential for expression of viral transcripts coding for the virion components and
thus represents a potential target for virus eradication. We present an overview of the
functional properties of the HTLV-1 and HTLV-2 Rex proteins (Rex-1 and Rex-2), outline
mechanisms controlling Rex function, and discuss similarities and differences in the
sequences of Rex coded by HTLV-1, -2, -3, and -4 that may influence their molecular
anatomy and functional properties.
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INTRODUCTION
Human T-lymphotropic virus type 1 (HTLV-1) infects approximately 10 million persons worldwide
(Willems et al., 2017). HTLV-1 is the causative agent of adult T-cell leukemia/lymphoma (ATLL),
tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM) and several inflammatory
diseases (Futsch et al., 2017). HTLV-1 is classified in seven molecular subtypes, named a, b, c, d,
e, f, and g, with characteristic geographic distributions in several endemic regions (Gessain and
Cassar, 2012). The closely related virus HTLV-2 circulates as two major subtypes, named a and
b, mainly in indigenous populations of South America and western and central Africa, and in
injection drug users (Roucoux and Murphy, 2004). Although the pathogenic spectrum of HTLV-2
is not clearly defined (Ciminale et al., 2014), infection with this virus may be associated with
neurological disease (Araujo and Hall, 2004) and appears to significantly increase all-cause and
cancer-related mortality (Biswas et al., 2010). Two other HTLVs, named HTLV-3 (Calattini et al.,
2005; Wolfe et al., 2005) and HTLV-4 (Switzer et al., 2009), were identified in individuals living
in the rainforests of Cameroon and are of unknown pathogenicity (Mahieux and Gessain, 2011).
The HTLVs are classified in the Deltaretrovirus genus, which also includes the closely related
simian T-lymphotropic viruses and bovine leukemia virus. Deltaretroviruses are considered to be
“complex” retroviruses, as they produce regulatory and accessory proteins and exhibit 2-phase
expression of alternatively spliced mRNAs (Cullen, 1991; Cavallari et al., 2011).
The replication cycle of the HTLVs (and all Deltaretroviruses) is controlled by the viral
regulatory proteins Tax and Rex, which are coded in open reading frames (ORFs) named x-IV and
x-III, respectively, located on the plus-strand of the proviral genome. Tax increases transcription
from the 5′LTR promoter as well as the promoters of many cellular genes, and plays a key role in
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viral replication and cell transformation (Romanelli et al., 2013).
As illustrated in Figure 1, Rex regulates viral mRNA expression at
the post-transcriptional level by interacting with a complex stem-
loop RNA structure termed the Rex-responsive element (RXRE),
present at the 3′ portion of all plus-strand viral transcripts. This
interaction relieves the inhibitory effects of the RXRE and of cis-
acting repressive sequences (CRS) present in incompletely spliced
mRNAs, rescues these mRNAs from splicing or degradation, and
allows their exit from the nucleus through a pathway mediated
by the cellular export factor CRM1 (also referred to as exportin
1/XPO1) (Younis and Green, 2005).
The RXRE is located in the 3′LTR, with RXRE-1 mapping
to a short portion of U3 and most of R (Toyoshima et al.,
1990) and RXRE-2 including the entire R segment and a
small portion of U5 (Kim et al., 1991). Its stem-loop structure
brings the polyadenylation signal close to the polyadenylation
site (Bar-Shira et al., 1991), ensuring efficient polyadenylation
of viral mRNAs. This position suggests that all transcripts,
including multiply spliced species, may have some degree of
Rex-responsiveness; this was confirmed for constructs expressing
HTLV-1 spliced mRNAs as intronless cDNAs (D’Agostino et al.,
1999; Bai et al., 2012). An incomplete RXRE (R for RXRE-1
and R-U5 for RXRE-2) is also present at the 5′ end of the
unspliced transcript.
In addition to CRS, introns and the RXRE, HTLV transcripts
contain multiple stop codons, two ribosomal frameshifting
signals and multiple splice acceptors that could be recognized
by the non-sense-mediated decay (NMD) machinery. A study
of HTLV-1-infected cells provided evidence that Rex contributes
to suppress NMD of viral and cellular transcripts through a
mechanism that does not involve interaction with the RXRE
(Nakano et al., 2013). Results of in vitro experiments suggest that
Rex-1 may also interfere with the activity of Dicer (Abe et al.,
2010), a key component of the siRNA- and microRNA processing
machinery. Its interactions with NMD and Dicer-dependent
pathways suggest that Rex may have broad effects on cellular RNA
processing and expression.
Studies of Rex and its HIV homolog Rev have contributed
substantially to our knowledge of RNA processing as well
as nucleo-cytoplasmic shuttling of proteins and RNA (Shida,
2012; Nakano and Watanabe, 2016; Rekosh and Hammarskjold,
2018). The following sections provide a brief description of
Rex coded by HTLV-1 and HTLV-2, referred to as Rex-1 and
Rex-2, respectively, and point out mechanisms that control Rex’s
activity. We also comment on similarities and differences in the
sequences of Rex-1, Rex-2, and Rex proteins coded by HTLV-3
and HTLV-4, whose activities have not been studied to date, and
highlight aspects of Rex function that remain to be understood.
FUNCTIONAL DOMAINS IN REX-1 AND
REX-2
Almost all of the information on Rex was gathered from studies
of Rex-1 coded by subtype-a isolate ATK-1 and Rex-2 coded by
subtype-a isolate Mo. Rex-1 (ATK-1) and Rex-2 (Mo) contain
189- and 170 amino acids, respectively, and four main functional
domains (Figure 2A; Younis and Green, 2005; Shida, 2012).
An amino-terminal, arginine-rich nuclear/nucleolar localization
signal (NLS) targets Rex to the nucleus through binding to
importin β. This sequence also functions as an RNA binding
domain (RBD) that mediates binding to the RXRE. A centrally
positioned nuclear export sequence (NES) mediates binding of
Rex to CRM1. The NES is flanked by two regions required for
the formation of Rex multimers, a process that is facilitated by
interaction with CRM1. A phosphorylation-regulated carboxy-
terminal domain enhances Rex’s stability and function (Kesic
et al., 2009a,b; Xie et al., 2009).
Figure 2B shows a CLUSTAL alignment of Rex-1 (ATK-1),
Rex-2 (Mo) and the Rex-3 and Rex-4 proteins coded by 2
full-length HTLV-3 and HTLV-4 isolates (GenBank nos. listed
in Supplementary Table 1). Overall, the NLS/RBD and NES
show higher sequence identity compared to the multimerization-
and stability domains. However, 9 of the 21 residues comprising
Rex-2’s stability domain show perfect identity among the Rex
proteins, suggesting a conserved functional role for this region.
Percent-identity calculations showed that Rex-1 (ATK-1) is more
similar to Rex-2 (Mo) than to Rex-3 or Rex-4, while Rex-2 (Mo)
is most similar to Rex-4 (see Supplementary Table 2).
Rex-1 proteins coded by isolates of subtypes a, b, and c
also showed some variation, especially between subtype-a and
subtype-c ORFs (86.77–88.36% identity, see Supplementary
Table 3). One subtype-a isolate, from an ATL patient in
Iran, codes for Rex with 20 additional carboxy-terminal amino
acids, a feature that might influence its stability domain (see
Supplementary Figure 1). Alignments of 11 Rex-2 ORFs (5
subtype-a and 6 subtype-b) revealed 93.53–95.88% identity
between the two subtypes (Supplementary Table 4), with distinct
“signatures” of amino acids at positions 104, 105, 123, 126, and
136 (see arrows in Supplementary Figure 1). Interestingly, Rex-2
(Mo) was not the most common subtype-a sequence.
CONTROL OF REX FUNCTION BY
PHOSPHORYLATION
Early studies of Rex-1 showed that it migrates as a 27-kDa
band in SDS-PAGE and is phosphorylated on multiple
serines and threonines (Adachi et al., 1990, 1992). Mass
spectrometry analysis of Rex-1 (ATK-1) (Kesic et al., 2009a)
identified phosphorylation of Thr-22, Ser-36, Thr-37, Ser-70,
Ser-97, Ser-106, and Thr-174 (see Figure 2A). Assays with
a Gag-RXRE reporter plasmid and Rex-1 (ATK-1) mutants
carrying phosphoablative (alanine) and phosphomimetic
(aspartic acid) substitutions of these residues indicated that
phospho-Ser-97, located in the NES, and phosho-Thr-174,
located in the stability domain, contribute substantially to Rex
activity (Kesic et al., 2009a).
Five of the seven phosphoacceptor sites identified in Rex-1
(ATK-1) (i.e., Thr-22, Ser-36, Thr-37, Ser-97, and Thr-174;
Figure 2C) are conserved across the 15 HTLV-1 isolates aligned
in Supplementary Figure 1. It is noteworthy that Ser-36 and
Ser-97 are also conserved in Rex-2, Rex-3, and Rex-4 (see
Supplementary Figure 1).
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FIGURE 1 | Functional activities described for Rex. See text for description. Interference with NMD and Dicer were described for Rex-1. The figure was made using
SMART images (https://smart.servier.com).
The Rex-2 (Mo) ORF produces two isoforms of 24- and
26 kDa that differ in phosphorylation (Green et al., 1991).
Mass spectrometry analysis (Kesic et al., 2009b) showed that
p26-Rex-2 is phosphorylated on Thr-19, Ser-117, Ser-125,
Ser-151, Ser-153, and Thr-164 (see Figure 2A), while p24Rex-2
is phosphorylated on Ser-117 and Thr-164. Functional assays on
point mutants revealed an important role for phosphorylation on
Ser-151, Ser-153, and Thr-164, with phospho-Ser-151 particularly
important for Rex-2’s ability to accumulate in the nucleus,
bind to the RXRE and exert full functional activity (Narayan
et al., 2001, 2003; Kesic et al., 2009b). These studies also
suggested that sequential phosphorylation of Thr-164 followed
by Ser-151 and Ser-153 converts the protein from a closed to
an open conformation that exposes the NLS/RBD (Kesic et al.,
2009b). Residues equivalent to Thr-19, Ser-125, and Thr-164 are
present in all of the Rex proteins aligned in Supplementary
Figure 1 (Figure 2C). The position of Thr-164 in a conserved
region known to be important for stability and activation
of Rex-2 suggests that it might be functionally relevant in
all Rex proteins.
The protein kinases responsible for Rex phosphorylation
have not been experimentally identified. Analysis of the Rex-
1 (ATK-1) and Rex-2 (Mo) ORFs with the NetPhos and
ScanSite prediction tools yielded one or more candidate kinases
for most of the phosphoacceptor sites identified by mass
spectrometry (Kesic et al., 2009a,b) as well as many other
potential phosphoacceptor sites and kinases (Supplementary
Table 5). Although the NetPhos and ScanSite predictions in
general showed little agreement, both algorithms identified
kinases potentially targeting Ser-97 in Rex-1 and the equivalent
serine in Rex-2, Rex-3, and Rex-4 (Supplementary Table 5). Its
conservation and position within the NES suggests that Ser-97
phosphorylation might influence Rex’s interaction with CRM1
and thereby modulate the nuclear export of cargo RNA.
Most of the studies of Rex phosphorylation have been
carried out in cell lines of non-lymphoid derivation (e.g., 293T,
Cos, HeLa) transfected with Rex expression plasmids. As the
expression of protein kinases can be highly cell-type specific,
it will be important to study the protein in cells that are
natural targets of HTLV infection in vivo – predominantly
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FIGURE 2 | Domain structure and sequence comparison of HTLV Rex proteins. (A) shows the functional domain structure of Rex-1 and Rex-2. Positions of
phosphoacceptor sites identified in Rex-1 (ATK-1) (Kesic et al., 2009a) and Rex-2 (Mo) (Kesic et al., 2009b) are indicated in red type. Diagrams are modified from
Kesic et al. (2009a,b). (B) shows a multiple sequence alignment of Rex proteins obtained with Clustal Omega (http://www.ebi.ac.uk/Tools/msa/clustalo/). Amino
acids are labeled in different colors according to their biochemical properties (red, small/hydrophobic; blue, acidic; magenta, basic; green,
hydroxyl/sulfhydryl/amine/Glycine). Asterisks indicate single conserved residues; and periods indicate residues with similar properties. GenBank Accession IDs:
HTLV-1 (ATK-1): J02029.1; HTLV-2 (Mo): M10060.1; HTLV-3 (Pyl 43): DQ462191.1; HTLV-4 (1863LE): EF488483.1 (see also Supplementary Figure 1). Tables in
(C) show conservation of the indicated serines and threonines in Rex-1 and Rex-2 proteins coded by the panel of 28 viral isolates listed in Supplementary Table 1.
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CD4 + T-cells for HTLV-1 (Richardson et al., 1990; Melamed
et al., 2015) and CD8 + T-cells for HTLV-2 (Ijichi et al., 1992;
Melamed et al., 2014). The identification of Rex’s functionally
relevant phospho-acceptor sites in these cells may have clinical
implications, as inhibitors for some of the kinases predicted
by NetPhos and ScanSite are already used in cancer therapy
(Roskoski, 2019).
TRUNCATED REX ISOFORMS
As depicted in Figure 3, Tax and Rex are expressed from a
doubly spliced, bicistronic mRNA containing exons 1, 2, and 3.
In addition to mRNA 1-2-3, HTLV-1, and HTLV-2 also produce
transcripts that code for truncated forms of Rex. In HTLV-1,
an mRNA that contains exon 1 linked to exon 3 (Orita et al.,
1991) produces p21Rex, whose initiator methionine corresponds
to methionine 79 of full-length Rex-1. p21Rex contains the
NES, second multimerization domain segment and C-terminal
stability domain of Rex-1, but lacks the N-terminal RBD/NLS
(Figure 3A). While two studies indicated that p21Rex does not
alter the function of full-length Rex-1 (Ciminale et al., 1997;
Bai et al., 2012), another indicated an inhibitory effect (Heger
et al., 1999), and a fourth study indicated that p21Rex, similar to
full-length Rex, stabilizes the unspliced transcript through NMD
inhibition (Nakano et al., 2013). Met-79 is present in all of the
Rex ORFs examined in Supplementary Figure 1, so all of these
viruses should be able to express p21Rex.
In HTLV-2, spliced mRNAs 1-3 and 1-B code for truncated
Rex-2 proteins named p22/p20Rex and p17Rex (Ciminale et al.,
1997; Figure 3B). These mRNAs also contain the x-II ORF, which
codes for the regulatory protein p28 (Ciminale et al., 1995).
The p22/20Rex isoforms initiate at Met-33 of full-length Rex-
2 and contain both segments of the multimerization domain,
FIGURE 3 | Rex isoforms coded by HTLV-1 (A) and HTLV-2 (B). mRNAs coding for Tax/Rex and Rex isoforms are indicated on the left. The Tax and Rex ORFs are
indicated by yellow and blue boxes, respectively, and the HTLV-2 p28 (x-II) ORF is indicated by a light purple box. The domain structures of Rex isoforms are
indicated on the right. The red X indicates a stop codon upstream of the exon 3 splice acceptor that is in frame with the Tax ORF. p16Rex is a very low-abundance
truncated Rex-2 isoform (Ciminale et al., 1995).
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the NES and the stability domain, while p17Rex starts at Met-
63. Functional analyses of p22/p20 showed that they sequester
full-length Rex-2 in the nucleus and interfere with its ability
to activate expression of a RXRE-dependent RNA reporter.
This effect was attributed to changes in Rex-2 phosphorylation
induced by the truncated proteins rather than through the
formation of inactive heteromultimers (Ciminale et al., 1997).
While Met-33 is not present in any of the 15 Rex-1 proteins
or in Rex-3 shown in Supplementary Figure 1, it is present
in 10 out of 11 Rex-2 proteins and in Rex-4. It is noteworthy
that the Rex-1 ORFs coded by 2 Australian isolates examined
in Supplementary Figure 1 contain a methionine seven codons
downstream the position aligning with Met-33. These isolates,
as well as HTLV-4, thus have the potential to produce proteins
similar to p22/p20Rex and p21Rex.
FUNCTIONAL REX ISOFORMS
A search for novel monocistronic HTLV-1 transcripts coding
for only Tax or Rex revealed the production of mRNAs that
contain exons 1 and 2 linked to splice acceptors (SA) located
upstream (C, Ca) or downstream (3a) of the canonical exon
3 SA; the use of these SA results in insertion or deletion
of amino acids in the Rex ORF just after the NLS/RBD
(Figure 3A; Rende et al., 2015). Transcripts 1-2-C and 1-2-
Ca code for longer Rex-1 isoforms named Rexb (214 a.a.)
and Rexc (213 a.a.), respectively, but do not produce Tax, and
mRNA 1-2-3a produces a 185-residue Rex-1 isoform named Rexa
and a Tax isoform lacking four amino-proximal amino acids.
Results of functional assays showed that all three Rex isoforms
are functionally active. However, Rexb and Rexc are mainly
cytoplasmic, suggesting that their extra amino acids affect the
NLS and/or NES (Rende et al., 2015). It will be interesting to
compare the expression of the alternatively spliced Tax/Rex and
Rex isoform mRNAs in the context of asymptomatic infection
and HTLV-1-associated pathologies.
The possibility that the other HTLVs produce analogous
Rex isoforms remains to be investigated. SAs C, Ca and 3a
are present in all 15 HTLV-1 isolates listed in Supplementary
Table 1. However, six of the isolates, including the prototype
ATK-1, contain a stop codon between SAs C and 3, and are
thus predicted to produce Rexa but not Rexb or Rexc. Among
the HTLV-2, HTLV-3, and HTLV-4 isolates in Supplementary
Table 1, all but one are likewise predicted to produce a Rexa-
like protein but not Rexb or Rexc due to the absence of
the corresponding SAs and presence of one or more stop
codons. HTLV-2b isolate Gu lacks all three alternative SAs and
contains stop codons, and thus should not produce any of the
extra Rex isoforms.
THE TWO-PHASE MODEL OF HTLV
EXPRESSION AND VIRAL LATENCY
The first investigation of HTLV-1 mRNA expression kinetics,
performed by transfecting a full-length HTLV-1 provirus
and northern blotting, revealed early (Rex-independent)
expression of multiply spliced mRNA and late (Rex-dependent)
accumulation of singly spliced and unspliced mRNA (Hidaka
et al., 1988). This two-phase model was supported and refined
by time-course studies that employed quantitative RT-PCR with
splice-site specific primers to detect individual alternatively
spliced transcripts. Experiments performed in 293T cells
transfected with an HTLV-1 molecular clone confirmed early
accumulation of the Tax/Rex mRNA followed by a steady increase
in the unspliced transcript and singly spliced env mRNA, but
did not indicate Rex-dependence of other alternatively spliced
species (Li et al., 2009, 2012). In partial contrast with these
results, analyses of transfected and infected cell lines and cells
from infected patients revealed that some of the alternatively
spliced transcripts coding for accessory/regulatory proteins
accumulate during the late phase together with the unspliced
Gag-Pro-Pol and singly spliced Env mRNAs, indicating their
Rex-dependence (Rende et al., 2011; Cavallari et al., 2016).
All of the late mRNAs contain a 75-nucleotide 3′ CRS located
between the splice acceptors for exons C and 3 that is absent
from the Rex-independent mRNAs (Cavallari et al., 2016).
These experiments also showed that mitosis partially overcomes
the Rex-dependence of some transcripts, suggesting that Rex
function is critical in the context of resting or slowly dividing
cells (Cavallari et al., 2016). The 2-phase timecourse of mRNA
expression was also evident in studies demonstrating the ability
of Rex and p21Rex to block NMD (Nakano et al., 2013).
Mathematical modeling of HTLV-1 expression indicated the
requirement for a delay in Rex function compared with Tax in
order to support the 2-phase kinetics observed experimentally
(Corradin et al., 2010). However, it is difficult to explain how
Rex function might be delayed compared to Tax, given their
co-expression by mRNA 1-2-3 (an early transcript). Possible
contributing factors include (i) the shorter half-life of Tax and
progressive accumulation of Rex, which is relatively stable (Rende
et al., 2011); (ii) the temporal pattern of expression of potential
FIGURE 4 | Factors controlling Rex function. Summarized are factors that
promote (→) and interfere with (a) Rex function, as described in the text.
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inhibitors of Rex (e.g., p21Rex mRNA 1-3, expressed early);
and (iii) late-phase accumulation of the monocistronic
mRNAs coding for functional Rex isoforms Rexb and
Rexc but not Tax.
It is also possible that changes in the availability of
cellular factors influence the relative activity of the 2 proteins
during the expression cycle. An example is heterogenous
nuclear ribonucleoprotein A1 (hnRNP A1), an important
regulator of RNA processing that was shown to interfere
with Rex function by competitively binding to the RXRE
(Duc Dodon et al., 2002) (Figure 4).
Recent studies indicated that individual HTLV-1-infected
cells undergo alternating bursts of viral gene expression and
latency (Billman et al., 2017; Mahgoub et al., 2018). Shut-
down of viral gene expression following the burst phase
may involve the activity of the late-phase protein p30Tof, a
nuclear/nucleolar product of the x-II ORF (Ciminale et al., 1992;
Koralnik et al., 1993). In addition to important transcriptional
effects, p30Tof blocks the Tax/Rex mRNA in the nucleus
(Nicot et al., 2004), a property shared by the HTLV-
2 x-II ORF protein p28 (Anupam et al., 2013). p30Tof
also binds directly to Rex-1, resulting in interference with
RXRE binding (Sinha-Datta et al., 2007) and failure to
export RXRE-containing RNA cargo (Baydoun et al., 2007).
Analyses of the intranuclear trafficking of Rex-1 showed
that it normally encounters CRM1 within the nucleoli, and
then travels as Rex-CRM1 complexes to nucleoplasmic foci,
where it binds to RXRE-containing mRNA that will eventually
be exported through the nuclear pore complex. p30/Tof
blocks Rex-CRM1 complexes in the nucleoli, thus precluding
their interaction with RNA cargo and blocking the RNA
export leg (Baydoun et al., 2007). HBZ, a multifunctional
regulatory protein coded on the minus strand of HTLV-1 (Ma
et al., 2016), was also shown to interfere with Rex function
(Philip et al., 2014) (Figure 4).
Studies of HTLV-2 expression kinetics indicated a similar
2-phase pattern of mRNA production (Bender et al., 2012).
The observed late-phase expression of abundant levels of
mRNA 1-3, coding for p22/20Rex and p28, suggests that
these proteins may engage a negative feedback loop in
the late phase through p22/p20Rex-mediated interference
with Rex function and through p28-mediated retention
of the Tax/Rex mRNA in the nucleus (Younis et al.,
2004), thus favoring a shut-down of productive infection
(Bender et al., 2012). The influence of the HTLV-2
minus-strand protein APH-2 on Rex function remains to
be investigated.
CONCLUSION AND PERSPECTIVES
Comparisons of the biological properties of wild-type and
Rex-defective HTLV-1 molecular clones indicated that while
Rex is not essential for in vitro immortalization of cultured
T-cells (a hallmark of HTLV-1 and HTLV-2), it is required
for establishment of persistent infection in a rabbit model
(Ye et al., 2003). This is an important finding, as persistent
viral replication is considered to be a key factor that
drives the inflammatory response to HTLV-1, with risk for
developing TSP/HAM, and ensures the generation of a vast
population of infected cells at risk for neoplastic transformation
(Bangham, 2018).
The discovery of Rex-1 as an essential factor for expression
of Gag/Pro/Pol RNA (Inoue et al., 1986) opened up a research
field that yielded a wealth of information on the mechanisms
regulating retroviral gene expression as well as cellular mRNA
processing pathways. Further studies of Rex are needed in
order to understand how its activity may be fine-tuned through
phosphorylation and interactions with alternative Rex isoforms,
other HTLV regulatory proteins, and cellular factors involved
in mRNA processing, export and translation (Figure 4). These
control points could be of key importance to turn on and
off Rex function during the early/late phases the kinetics of
expression of viral genes as well as in the bursts of expression
revealed by the more recent single-cell analysis. It will be
critical to focus future investigations of Rex-controlled HTLV
gene expression on the natural cell targets of the virus, and
to determine whether Rex phosphorylation, function and the
pattern of splicing of viral transcripts change over time in infected
individuals and, in the case of HTLV-1, are associated with
development of disease. Answers to these questions could also
pave the way to the development of novel therapeutic strategies
to eradicate HTLV infection.
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